ArticleFrontiers in medicine2026
Distribution of lower limb muscles may be associated with the progression of knee osteoarthritis and sarcopenia: a cross-sectional study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to delineate and segment the distribution of lower limb muscles based on full-length anteroposterior digital radiography (DR) of patients with varus knee osteoarthritis (vKOA), to quantitatively assess regional muscle abundance, and to explore its associations with vKOA progression and the risk of sarcopenia (SP). Methods: A total of 79 vKOA patients (124 lower limbs) admitted to the Joint Center of the Third Affiliated Hospital of Guangzhou University of Chinese Medicine between January 2023 and January 2024 were enrolled according to predefined inclusion and exclusion criteria. Inclusion criteria were: knee pain within the past month, age ≥ 50 years, morning stiffness < 30 min, and radiographic findings of joint space narrowing, subchondral sclerosis and/or cystic changes, and osteophyte formation. Exclusion criteria were: valgus KOA or other forms of arthritis, concomitant diseases affecting lower limb function, lower limb deformities of other etiologies, and inability to comply with data collection. Demographic and clinical information, including sex, age, height, weight, body mass index (BMI), diabetes, and hypertension, were collected. From DR images, muscle area indices were extracted from five anatomical sites: femoral lateral muscle, femoral medial muscle, tibial medial muscle, crural interosseous muscle, and lateral fibular muscle. Varus KOA related parameters, including hip-knee-ankle angle (HKA), joint line convergence angle (JLCA), medial joint space width (MJSW), and lateral joint space width (LJSW), were recorded. Appendicular skeletal muscle mass index (ASMI) was obtained using dual-energy X-ray absorptiometry (DXA). Patients were categorized into SP with vKOA (SP-vKOA) and vKOA groups according to the Asian Working Group for Sarcopenia criteria, and into mild vKOA (Kellgren-Lawrence grade 1-2) and severe vKOA (grade 3-4) groups. Intergroup analyses were performed using the rank-sum test, independent-sample Results: Binary logistic regression indicated that the tibial medial muscle area index (TMMAI) [odds ratio ( Conclusion: In patients with vKOA, atrophy of the femoral lateral muscle and imbalance in femoral medial-to-lateral muscle distribution may contribute to vKOA progression, while atrophy of the tibial medial muscle may be linked to the development of SP. Targeted rehabilitation strategies focusing on specific muscle groups in vKOA patients may help alleviate disease progression and reduce the incidence of SP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.